1 / 3Off the Scales: The Inside Story of Ozempic and the Race to Cure Obesity
Inside Story Race Cure: Off the Scales is Aimee Donnellan’s account of the development and rise of Ozempic and the wider debate around obesity treatments. It examines the science, commercial competition and social questions, including inequality, beauty ideals and the pursuit of thinness.
At a glance
- Covers the development of Ozempic and the emergence of a competitive market for weight-loss injections.
- Connects GLP-1 research and pharmaceutical business with wider effects on healthcare and other industries.
- Explores questions of inequality, morality, beauty ideals and the pursuit of thinness.
- Includes profiles of an overlooked female scientist and accounts from some early Ozempic users, according to the listing.
Reference price: £20.00
Price checked: 12 Nov 2026
View offerAhead of Black FridayExplore the selectionOften bought together
Pros and cons
Pros
- Combines the drug’s development story with discussion of its public-health, commercial and cultural implications.
- The listing describes original reporting and research, alongside profiles and early-user accounts.
Technical specifications
8 specifications| Publisher | Fourth Estate |
|---|---|
| Publication date | 15 Jan. 2026 |
| Language | English |
| Print length | 320 pages |
| ISBN-10 | 000871908X |
| ISBN-13 | 978-0008719081 |
| Weight listed | 520 g |
|---|---|
| Dimensions | 15.9 x 3.4 x 24 cm |
Who is it for?
Customer reviews on Amazon
- 5 stars
41% 41% - 4 stars
31% 31% - 3 stars
15% 15% - 2 stars
7% 7% - 1 star
6% 6%
The supplied evidence includes aggregate ratings but no customer-comment summary. The ratings are mixed rather than uniformly favourable. They provide only a broad indication of reader reception and do not establish which aspects readers liked or disliked.
Frequently asked questions
What does Off the Scales cover?
The listing describes a history of Ozempic’s development and rise, with attention to GLP-1 research, pharmaceutical competition, public health and social consequences.
Does the book focus only on the science?
No. Its described scope also includes business, healthcare, inequality, morality, beauty ideals and the pursuit of thinness.
Who is the author?
The listing names Aimee Donnellan.
Alternative options
BIG PHARMA - CRIMINAL MASTERMINDS: FIRST DO NO HARM!
£22.99
A Bloody Scandal: How Medicine Fails Women in Pain
£15.39
The Complete Financial History of Berkshire Hathaway: A Chronological Analysis of Warren Buffett and Charlie Munger's Conglomerate Masterpiece
£32.05
The Big Fat Swap: The Great Food Experiment We Did Not Consent To — And How To Opt Out (Health Span Series)
£14.99
End Sugar Addiction Now: The No-nonsense Guide to Losing Weight, Eliminating Cravings and Increasing Energy and Longevity to Lead the Life You Desire
£8.99
Days of Love and Rage: A Story of Revolution - Shortlisted for The Baillie Gifford Prize 2026
£21.00
Why We Can't Lose Weight: And What To Do About It. The Science of Metabolism, Hormones and Fat Loss. Why Diets Fail, What’s Really Blocking Your ... From The Sunday Times Best Selling Author.
£16.99
Money to Burn: Leon Black, Apollo and the Remaking of Wall Street
£30.35
The Elements of Power: A New Yorker writer uncovers the darker side of the green revolution – 'An unflinching, landmark work' Patrick Radden Keefe
£15.95
Ausländer: One family's story of escape and exile
£18.80
The Rise and Fall of the Artificial State
£18.84
Adrift in the South
£11.05
